Publications in collaboration with researchers from South Texas Accelerated Research Therapeutics (1)

2016

  1. A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma

    Leukemia and Lymphoma, Vol. 57, Núm. 8, pp. 1848-1855